13D/13G Filings - Vistagen Therapeutics Inc. (VTGN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
5:20 pm
Sale		2022-12-3113GVistaGen Therapeutics, Inc.
VTGN		ORBIMED ADVISORS LLC0
0.000%		-350,641decrease
(Position Closed)		Filing
History
2023-02-14
4:06 pm
Sale		2022-12-3113GVistaGen Therapeutics, Inc.
VTGN		Commodore Capital LP0
0.000%		-348,530decrease
(Position Closed)		Filing
History
2023-02-14
3:32 pm
Sale		2022-12-3113GVistaGen Therapeutics, Inc.
VTGN		ACUTA CAPITAL PARTNERS LLC0
0.000%		-391,209decrease
(Position Closed)		Filing
History
2023-02-01
4:54 pm
Purchase		2022-12-3113GVistaGen Therapeutics, Inc.
VTGN		BlackRock Inc.
BLK		408,932
5.900%		12,459increase
(+3.14%)		Filing
History
2023-02-01
1:49 pm
Sale		2022-12-3113GVistaGen Therapeutics, Inc.
VTGN		FRANKLIN RESOURCES INC
BEN		0
0.000%		-337,267decrease
(Position Closed)		Filing
History
2022-08-12
5:15 pm
Sale		2022-07-2213DVistaGen Therapeutics, Inc.
VTGN		Growth Equity Opportunities 17 LLC0
0.000%		-543,420decrease
(Position Closed)		Filing
History
2022-07-08
4:05 pm
Purchase		2022-04-0613GVistaGen Therapeutics, Inc.
VTGN		Venrock Healthcare Capital Partners II, L.P.689,910
10.000%		155,000increase
(+28.98%)		Filing
History
2022-04-14
4:42 pm
Purchase		2022-04-0413GVistaGen Therapeutics, Inc.
VTGN		Commodore Capital LP348,530
5.100%		348,530increase
(New Position)		Filing
History
2022-02-15
2:51 pm
Sale		2021-12-3113GVistaGen Therapeutics, Inc.
VTGN		ACUTA CAPITAL PARTNERS LLC391,209
5.900%		-24,290decrease
(-5.85%)		Filing
History
2022-02-14
4:20 pm
Purchase		2021-12-3113GVistaGen Therapeutics, Inc.
VTGN		Venrock Healthcare Capital Partners II, L.P.534,910
8.000%		60,235increase
(+12.69%)		Filing
History
2022-02-11
4:58 pm
Purchase		2021-12-3113GVistaGen Therapeutics, Inc.
VTGN		ORBIMED ADVISORS LLC350,641
5.300%		24,681increase
(+7.57%)		Filing
History
2022-02-04
4:12 pm
Purchase		2021-12-3113GVistaGen Therapeutics, Inc.
VTGN		BlackRock Inc.
BLK		396,473
6.000%		396,473increase
(New Position)		Filing
History
2022-02-04
10:54 am
Purchase		2021-12-3113GVistaGen Therapeutics, Inc.
VTGN		FRANKLIN RESOURCES INC
BEN		337,267
5.100%		337,267increase
(New Position)		Filing
History
2021-04-29
10:17 am
Purchase		2021-03-2613DVistaGen Therapeutics, Inc.
VTGN		Growth Equity Opportunities 17 LLC543,420
8.600%		231,420increase
(+74.17%)		Filing
History
2021-03-22
06:06 am
Purchase		2021-03-1213GVistaGen Therapeutics, Inc.
VTGN		ACUTA CAPITAL PARTNERS LLC415,499
8.400%		165,499increase
(+66.20%)		Filing
History
2021-02-16
4:11 pm
Purchase		2020-12-3113GVistaGen Therapeutics, Inc.
VTGN		Venrock Healthcare Capital Partners II, L.P.474,675
9.990%		474,675increase
(New Position)		Filing
History
2021-02-16
06:14 am
Purchase		2020-12-3113GVistaGen Therapeutics, Inc.
VTGN		ACUTA CAPITAL PARTNERS LLC250,000
5.400%		250,000increase
(New Position)		Filing
History
2021-02-12
5:12 pm
Purchase		2020-12-3113GVistaGen Therapeutics, Inc.
VTGN		ORBIMED ADVISORS LLC325,960
6.900%		325,960increase
(New Position)		Filing
History
2021-01-22
5:26 pm
Purchase		2020-12-3113GVistaGen Therapeutics, Inc.
VTGN		Rosalind Advisors, Inc.179,237
4.800%		45,904increase
(+34.43%)		Filing
History
2021-01-04
06:00 am
Purchase		2020-12-2213DVistaGen Therapeutics, Inc.
VTGN		Growth Equity Opportunities 17 LLC312,000
6.800%		312,000increase
(New Position)		Filing
History
Goto Prev, 0, 1, 2, Next